ZCL 278CAS号： 587841-73-4分子式： C21H19BrClN5O4S2分子量： 584.89描述纯度储存/保存方法别名外观可溶性/溶解性靶点In vitro(体外研究)In vivo(体内研究)
| 产品描述 | |
| 描述 |
ZCL278 是一种选择性的 Cdc42 调节剂，直接结合到 Cdc42，且抑制其功能，Kd 为 11.4 μM。 |
| 纯度 |
＞98%
|
| 储存/保存方法 |
Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.
|
| 基本信息 | |
| 别名 |
ZCL-278
|
| 外观 |
powder
|
| 可溶性/溶解性 |
DMSO : 50 mg/mL (85.49 mM; Need ultrasonic)
|
| 生物活性 | |
| 靶点 |
Cdc42 GTPase
|
| In vitro(体外研究) |
ZCL278 inhibits Cdc42 GTPase activity by the competition with GTP and inhibits Rac/Cdc42 phosphorylation in a time-dependent manner. ZCL278 (50 μM) inhibits Cdc42-mediated microspike formation and disrupts GM130-docked Golgi structures in serum-starved Swiss 3T3 fibroblasts. In addition, ZCL278 also suppresses Cdc42-mediated neuronal branching and growth cone dynamics as well as actin-based motility and migration in a metastatic prostate cancer PC-3 cell line without cytotoxicity.
|
| In vivo(体内研究) |
ZCL278 reduces the JUNV RNA load in the spleen more than 33-fold, with JUNV RNA being undetectable in 5 out of 8 mice. These results are similar to those seen in Gabapentin-treated mice, demonstrating that ZCL278 can abrogate JUNV replication.
|
分子结构图
